Dr. Amanda Bennett, MD
Developmental-Behavioral Pediatrics (Developmental - Behavioral Pediatrics Physician)
3550 Market St Fl 3, Children's Hospital Of Philadelphia - Child Development
Philadelphia, PA 19104
At a glance
- In the NPI registry since
- 2007
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Developmental - Behavioral Pediatrics Physician primary
PA license MD425237 -
Pediatrics Physician
PA license MD425237
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Developmental-Behavioral Pediatrics per capita by county →
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $22,412 in research payments for these studies, mostly to the institutions running them.
- Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder
Acadia Pharmaceuticals Inc · Completed · NCT05523895 - Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder
Acadia Pharmaceuticals Inc · Terminated · NCT05555615
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.